Latest Regulatory Approval News

Brazilian Critical Minerals Ltd has reported significant progress at its Ema rare earths project, achieving high recovery rates from in-situ recovery (ISR) tests and securing a $4 million capital raise to accelerate development.

Sandfire Resources reported a 12% rise in copper equivalent production for FY25, narrowly missing guidance due to severe weather and power outages, while slashing net debt by $273 million. The company projects further growth in FY26 despite expected cost pressures.

Patriot Resources has signed to acquire the high-grade Sugarloaf Copper Deposit in Zambia and commenced drilling on a fresh copper target, backed by a $2.2 million capital raise to accelerate exploration.

NuEnergy Gas Limited has completed drilling two wells at its Tanjung Enim PSC in Indonesia, advancing its early gas sales initiative targeting 1 million cubic feet per day. The company is finalizing a major gas sales agreement pending government approval.

Peninsula Energy reported a $5.3 million operating cash outflow for the June quarter and secured a $15 million debt facility to advance its Lance Project toward uranium production, expected by August 2025.

Peninsula Energy advances commissioning at its Lance uranium project, resets most sales contracts to reduce risk, and secures a $15 million debt facility to support production ramp-up.

Brightstar Resources secures backing from major Aurumin shareholders and option holders for its proposed acquisition, pending expert approval and absence of superior offers.

Moab Minerals is progressing its Manyoni uranium project with a planned JORC-compliant resource estimate and is nearing completion of a key tenement acquisition, while securing fresh funding to support ongoing exploration.

Peninsula Energy has completed a major reset of its uranium offtake contracts, terminating five of six agreements with a $6.6 million payout, while advancing commissioning of its Central Processing Plant toward first yellowcake production in Q3 2025.

Alterity Therapeutics has reported encouraging topline results from its open-label Phase 2 trial of ATH434 in advanced Multiple System Atrophy, showing slowed disease progression and biomarker stabilization.

Anax Metals has raised $3.3 million through convertible notes to push forward its Whim Creek copper-zinc project in Western Australia, while resolving a recent arbitration with its cornerstone investor Mineral Development Partners.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.